Skip to main content
. 2005 Dec;40(6 Pt 1):1836–1853. doi: 10.1111/j.1475-6773.2005.00436.x

Table 2.

Multivariate Regression Models* Relating Intensity of Antiglycemic Medication Therapy to Glycemic Control

Change in HbA1c Outcome HbA1c>8%


Variable Coefficient p-Value Odds Ratio 95% CI
Intensity of therapy (per increase of 0.1) −0.064 <.0001 0.91 0.88, 0.98
Index visit HbA1c 1.76 1.72, 1.81
Age (per increase of 10 years) 0.013 .39 0.78 0.75, 0.81
Male gender 0.147 .13 1.12 0.86, 1.45
Any diabetes complication −0.131 <.0001 1.29 1.18, 1.41
Charlson index 0.026 .01 1.02 0.99, 1.05
Psychiatric diagnosis 0.156 .0002 1.03 0.92, 1.15
Alcohol/substance abuse diagnosis −0.169 .06 0.79 0.62, 1.00
Oral steroid use −0.022 .75 0.83 0.69, 1.00
*

A linear model was used when modeling outcome visit HbA1c minus index visit HbA1c; a negative coefficient indicates improved glycemic control. A logistic model was used to predict odds of an outcome HbA1c>8%; an odds ratio less than 1.0 indicates better control

HbA1c, hemoglobin A1c; CI, confidence interval